Adjuvant chemotherapy for non-small cell lung cancer.
Publication
, Journal Article
D'Amico, TA
Published in: Semin Thorac Cardiovasc Surg
2005
The survival after complete resection for non-small cell lung cancer (NSCLC) is unsatisfactory. Until recently, the use of adjuvant therapy after resection for early stage disease has not been proven to improve survival. However, the efficacy of adjuvant therapy has been demonstrated in phase III prospective randomized trials. The appropriate use of adjuvant therapy, including biologic therapy, is currently under investigation.
Published In
Semin Thorac Cardiovasc Surg
DOI
ISSN
1043-0679
Publication Date
2005
Volume
17
Issue
3
Start / End Page
195 / 198
Location
United States
Related Subject Headings
- Respiratory System
- Quinazolines
- Protein Kinase Inhibitors
- Oncogene Proteins
- Lung Neoplasms
- Humans
- Gefitinib
- Erlotinib Hydrochloride
- Chemotherapy, Adjuvant
- Carcinoma, Non-Small-Cell Lung
Citation
APA
Chicago
ICMJE
MLA
NLM
D’Amico, T. A. (2005). Adjuvant chemotherapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg, 17(3), 195–198. https://doi.org/10.1053/j.semtcvs.2005.06.010
D’Amico, Thomas A. “Adjuvant chemotherapy for non-small cell lung cancer.” Semin Thorac Cardiovasc Surg 17, no. 3 (2005): 195–98. https://doi.org/10.1053/j.semtcvs.2005.06.010.
D’Amico TA. Adjuvant chemotherapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2005;17(3):195–8.
D’Amico, Thomas A. “Adjuvant chemotherapy for non-small cell lung cancer.” Semin Thorac Cardiovasc Surg, vol. 17, no. 3, 2005, pp. 195–98. Pubmed, doi:10.1053/j.semtcvs.2005.06.010.
D’Amico TA. Adjuvant chemotherapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2005;17(3):195–198.
Published In
Semin Thorac Cardiovasc Surg
DOI
ISSN
1043-0679
Publication Date
2005
Volume
17
Issue
3
Start / End Page
195 / 198
Location
United States
Related Subject Headings
- Respiratory System
- Quinazolines
- Protein Kinase Inhibitors
- Oncogene Proteins
- Lung Neoplasms
- Humans
- Gefitinib
- Erlotinib Hydrochloride
- Chemotherapy, Adjuvant
- Carcinoma, Non-Small-Cell Lung